262 related articles for article (PubMed ID: 32202208)
1. Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors.
Jacobs BM; Giovannoni G; Cuzick J; Dobson R
Mult Scler; 2020 Oct; 26(11):1281-1297. PubMed ID: 32202208
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis.
Xiao D; Ye X; Zhang N; Ou M; Guo C; Zhang B; Liu Y; Wang M; Yang G; Jing C
Sci Rep; 2015 Dec; 5():18083. PubMed ID: 26656273
[TBL] [Abstract][Full Text] [Related]
4. Smoking and Epstein-Barr virus infection in multiple sclerosis development.
Hedström AK; Huang J; Brenner N; Butt J; Hillert J; Waterboer T; Kockum I; Olsson T; Alfredsson L
Sci Rep; 2020 Jul; 10(1):10960. PubMed ID: 32620875
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
[TBL] [Abstract][Full Text] [Related]
6. The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review.
Ruprecht K
Expert Rev Clin Immunol; 2020 Dec; 16(12):1143-1157. PubMed ID: 33152255
[No Abstract] [Full Text] [Related]
7. Epstein-Barr virus cause of multiple sclerosis.
Tselis A
Curr Opin Rheumatol; 2012 Jul; 24(4):424-8. PubMed ID: 22617821
[TBL] [Abstract][Full Text] [Related]
8. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy.
Rød BE; Wergeland S; Bjørnevik K; Holmøy T; Ulvestad E; Njølstad G; Myhr KM; Torkildsen Ø
Mult Scler Relat Disord; 2023 Nov; 79():105037. PubMed ID: 37804765
[TBL] [Abstract][Full Text] [Related]
9. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence.
Ascherio A; Munger KL
Clin Exp Immunol; 2010 Apr; 160(1):120-4. PubMed ID: 20415861
[TBL] [Abstract][Full Text] [Related]
10. Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progression.
Tao C; Simpson-Yap S; Taylor B; Blizzard L; Lucas R; Ponsonby AL; Broadley S; van der Mei I;
Mult Scler Relat Disord; 2022 Mar; 59():103561. PubMed ID: 35131728
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus and multiple sclerosis.
Lucas RM; Hughes AM; Lay ML; Ponsonby AL; Dwyer DE; Taylor BV; Pender MP
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1142-8. PubMed ID: 21836034
[TBL] [Abstract][Full Text] [Related]
12. [Multiple sclerosis and Epstein-Barr virus : new developments and perspectives].
Ruprecht K
Nervenarzt; 2008 Apr; 79(4):399-407. PubMed ID: 17713752
[TBL] [Abstract][Full Text] [Related]
13. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
Lucas RM; Ponsonby AL; Dear K; Valery P; Pender MP; Burrows JM; Burrows SR; Chapman C; Coulthard A; Dwyer DE; Dwyer T; Kilpatrick T; Lay ML; McMichael AJ; Taylor BV; van der Mei IA; Williams D
Neurology; 2011 Jul; 77(4):371-9. PubMed ID: 21753179
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom.
Kuri A; Jacobs BM; Vickaryous N; Pakpoor J; Middeldorp J; Giovannoni G; Dobson R
BMC Public Health; 2020 Jun; 20(1):912. PubMed ID: 32532296
[TBL] [Abstract][Full Text] [Related]
15. Epstein-barr virus infection and multiple sclerosis: a review.
Ascherio A; Munger KL
J Neuroimmune Pharmacol; 2010 Sep; 5(3):271-7. PubMed ID: 20369303
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus candidate genes and multiple sclerosis.
Claire Simon K; Schmidt H; Loud S; Ascherio A
Mult Scler Relat Disord; 2015 Jan; 4(1):60-4. PubMed ID: 25787055
[TBL] [Abstract][Full Text] [Related]
17. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.
De Jager PL; Simon KC; Munger KL; Rioux JD; Hafler DA; Ascherio A
Neurology; 2008 Mar; 70(13 Pt 2):1113-8. PubMed ID: 18272866
[TBL] [Abstract][Full Text] [Related]
18. Follow-up after infectious mononucleosis in search of serological similarities with presymptomatic multiple sclerosis.
Jons D; Persson Berg L; Sundström P; Haghighi S; Axelsson M; Thulin M; Bergström T; Andersen O
Mult Scler Relat Disord; 2021 Nov; 56():103288. PubMed ID: 34634626
[TBL] [Abstract][Full Text] [Related]
19. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis.
Thacker EL; Mirzaei F; Ascherio A
Ann Neurol; 2006 Mar; 59(3):499-503. PubMed ID: 16502434
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications.
Bjornevik K; Münz C; Cohen JI; Ascherio A
Nat Rev Neurol; 2023 Mar; 19(3):160-171. PubMed ID: 36759741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
